OPS
LXRX icon

Orion Portfolio Solutions’s Lexicon Pharmaceuticals LXRX Stock Holding History

Orion Portfolio Solutions’s Portfolio LXRX Stock Details LXRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-18
Closed – – 1367
2020
Q2 		$0 Hold
18
– – ﹤0.01% 2343
2020
Q1 		$0 Hold
18
– – ﹤0.01% 2123
2019
Q4 		$0 Buy
+18
New +$69 ﹤0.01% 1882

Other funds holding LXRX

AG
Artal Group Luxembourg $931M AUM 41.63% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
UL
Ulys LLC New York $25.4M AUM 201.03% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Lazard Asset Management
Lazard Asset Management New York $66.1B AUM 33.53% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Orion Portfolio Solutions's LXRX Position: Q3 2020 in Review

Orion Portfolio Solutions sold out of Lexicon Pharmaceuticals (LXRX) in Q3 2020, closing a stake of 18 shares.

Orion Portfolio Solutions first reported a position in LXRX in Q4 2019 and held it in 3 quarters. The position peaked at $0 in Q2 2020. 91 funds tracked by Wall St. Rank hold LXRX as of Q3 2020.

  • Orion Portfolio Solutions reported no remaining Lexicon Pharmaceuticals position as of Q3 2020 after selling out during the quarter.
  • Orion Portfolio Solutions sold 18 Lexicon Pharmaceuticals shares in Q3 2020.
  • Orion Portfolio Solutions first reported a position in Lexicon Pharmaceuticals in Q4 2019 and held it in 3 quarters.
  • Orion Portfolio Solutions's Lexicon Pharmaceuticals position peaked at $0 in Q2 2020.
  • 91 funds tracked by Wall St. Rank held Lexicon Pharmaceuticals as of Q3 2020.

Based on Orion Portfolio Solutions's 13F filing for Q3 2020, filed 13 Nov 2020.